NIH-funded research R01 grant

Blood DNA methylation markers for long COVID (PASC)

Official title: Blood DNA Methylation Biomarkers of Post Acute Sequelae of SARS CoV 2 Infection (PASC)

Funded at Albany Medical College · NIH-11123263 · Data updated 2026-11-12

Researchers are looking for lasting chemical changes in blood DNA that might explain ongoing symptoms in people who had COVID-19.

More SARS-CoV-2 research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbany Medical College
NIH-funded
Lab location1 site (Albany, United States)
Project startJuly 5, 2023
Project endJune 30, 2028
Funding year2025
Award (this year)$774,571
NIH project number5R01AI173035-03
Project IDNIH-11123263 on NIH RePORTER

Who could benefit from this research

Could help

Adults who previously had SARS-CoV-2 infection, especially those experiencing ongoing post-COVID symptoms (PASC) or who were hospitalized for COVID-19, are the ideal candidates.

Less likely to help

People who never had COVID-19 or whose symptoms are clearly explained by other medical conditions are unlikely to benefit directly from this research.

What this research studies

You would be asked to give blood samples so researchers can look at chemical tags on your DNA (called methylation) and measure which genes are active. They will perform whole-genome DNA methylation testing and RNA sequencing on white blood cells collected after your COVID-19 illness. The team will compare people with ongoing post-COVID symptoms to those who recovered without lasting problems to find persistent differences. Those patterns could help define different types of long COVID and point to blood tests or new targets for treatments.

Why it matters

Potential benefit: If successful, this work could lead to blood-based biomarkers that help diagnose or categorize long COVID and suggest targets for future therapies.

How similar studies have gone: Prior studies have shown altered blood methylation during acute COVID and some signals persisting up to a year, but using genome-wide methylation profiles as clinical PASC biomarkers is still an emerging area.

Where this research is happening

  • Albany Medical College
    Albany, United States
    Active

Researchers

  • Principal investigator: Jaitovich, Adolfo Ariel — Albany Medical College
  • Study coordinator: Jaitovich, Adolfo Ariel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.